Logo image
Loss of α-Dystroglycan Laminin Binding in Epithelium-derived Cancers Is Caused by Silencing of LARGE
Journal article   Open access   Peer reviewed

Loss of α-Dystroglycan Laminin Binding in Epithelium-derived Cancers Is Caused by Silencing of LARGE

Daniel Beltrán-Valero de Bernabé, Kei-ichiro Inamori, Takako Yoshida-Moriguchi, Christine J Weydert, Hollie A Harper, Tobias Willer, Michael D Henry and Kevin P Campbell
The Journal of biological chemistry, Vol.284(17), pp.11279-11284
04/24/2009
DOI: 10.1074/jbc.C900007200
PMCID: PMC2670132
PMID: 19244252
url
https://doi.org/10.1074/jbc.C900007200View
Published (Version of record) Open Access

Abstract

The interaction between epithelial cells and the extracellular matrix is crucial for tissue architecture and function and is compromised during cancer progression. Dystroglycan is a membrane receptor that mediates interactions between cells and basement membranes in various epithelia. In many epithelium-derived cancers, β-dystroglycan is expressed, but α-dystroglycan is not detected. Here we report that α-dystroglycan is correctly expressed and trafficked to the cell membrane but lacks laminin binding as a result of the silencing of the like-acetylglucosaminyltransferase (LARGE) gene in a cohort of highly metastatic epithelial cell lines derived from breast, cervical, and lung cancers. Exogenous expression of LARGE in these cancer cells restores the normal glycosylation and laminin binding of α-dystroglycan, leading to enhanced cell adhesion and reduced cell migration in vitro. Our findings demonstrate that LARGE repression is responsible for the defects in dystroglycan-mediated cell adhesion that are observed in epithelium-derived cancer cells and point to a defect of dystroglycan glycosylation as a factor in cancer progression.

Details

Logo image